[Frontiers in Bioscience 3, d944-960, September 1, 1998]
Reprints
PubMed
CAVEAT LECTOR




Table of Conents
 Previous Section   Next Section

BIOLOGICAL AND MOLECULAR BASIS OF HUMAN BREAST CANCER

Jose Russo, Xiaoqi Yang, Yun-Fu Hu, Betsy A. Bove, Yajue Huang, Ismael D.C.G. Silva, Quivo Tahin, Yuli Wu, Nadia Higgy, Abdel Zekri, and Irma H. Russo

Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Received 12/17/97 Accepted 7/21/98

12. REFERENCES

1. S.L. Parker, T. Tong, S. Bolden & P.A. Wingo: Cancer statistics 1996. CA Cancer J Clin 46, 5-27 (1996)

2. S.L. Parker, T. Tong, S. Bolden & P.A. Wingo: Cancer Statistics. CA Cancer J Clin 47, 5-27 (1997)

3. J.W. Simons: Genetic, epigenetic, dysgenetic, and non-genetic mechanisms in tumorigenesis. Crit Rev Oncogenesis 6, 261-73 (1995)

4. R. Holliday: Neoplastic transformation: the contrasting stability of human and mouse cells. Cancer Survey 28, 103-15 (1996)

5. D. B. Couch: Carcinogenesis: basic principles. Drug Chem Toxicol 19, 133-48 (1996)

6. J. Russo, G. Calaf & I.H. Russo: A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit Rev Oncogenesis 44, 403-17 (1993)

7. J. Russo, N. Barnabas, N. Higgy, A.M. Salicioni, Y.L. Wu & I.H. Russo: Molecular basis of human breast epithelial cell transformation. In Breast Cancer. Advances in biology and therapeutics. Eds: Calvo F, Crepin M and Magdelenat H, John Libbey Eurotext (1996) pp33-43.

8. E. Farber: The multistep nature of cancer development.

Cancer Res 44, 4217-23 (1984)

9. G. Klein & E. Klein: Evolution of tumors and the impact of molecular oncology. Nature 315, 190-5 (1985)

10. D.J. Page & W.D. Dupont: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66, 1326-35 (1990)

11. J. Russo, D. Reina, J. Frederick & I.H.Russo: Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 48, 2837-57 (1988)

12. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D. Peterson, R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones & S.C.Brooks: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res 50, 6075-86 (1990)

13. J. Russo, G. Calaf, N. Sohi, Q. Tahin, P.L. Zhang, M.E. Alvarado, S. Estrada & I.H. Russo: Critical steps in breast carcinogenesis. Ann NY Acad Sci USA 698, 1-20 (1993)

14. Y.F. Hu, I.H. Russo, U. Zalipsky, H.T. Lynch & J. Russo: Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer. In Vitro Cell Dev Biol 33, 495-98 (1997)

15. R.G. Ham: Clonal growth of mammalian cells in a chemically defined synthetic medium. Proc Natl Acad Sci USA 53, 288-93 (1965)

16. S.L. Hammond, R.G. Ham & M.R. Stampfer: Serum-free growth of human mammary epithelial cells. rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci USA 81, 5435-9 (1984)

17. L. Tait, H.D. Soule & J. Russo: Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 50, 6087-6094 (1990)

18. M.J. Mills, M.J. Mousalli & J. Russo: DNA-labeling index and in vitro growth of mammary epithelium are modulated by the stage of gland development. Proc Int Assoc Breast Cancer Res, Miami, FL (1987)

19. M.J. Mousalli, M.J. Mills & J. Russo: Influence of mammary gland development on its epithelium's growth potential in tissue culture. Proc Int Assoc Breast Cancer Res, Miami, FL (1987)

20. V. Band: Preneoplastic transformation of human mammary epithelial cells. Sem Cancer Biol 6, 185-92 (1995)

21. A. Derventzi, S.I.S. Rattan & E. Gonos: Molecular links between cellular mortality and immortality. Anticancer Res 16, 2901-10 (1996)

22. U. Hopfer, J.W. Jacobberger, D.C. Gruenert, R.L. Eckert, R.S. Jat & J.A. Whitsett: Immortalization of epithelial cells. Am J Physiol 270, c1-c11 (1996)

23. R.F. Newbold: Multistep malignant transformation of mammalian cells by carcinogens: Induction of immortality as a key event. In: Carcinogenesis Vol 9. Eds: Barrett JC, Tennant RW, Raven Press, NY (1985) pp17-28.

24. V. Band, D. Zagetowski, V. Kulesa & R. Sager: Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 87, 463-7 (1990)

25. V. Band, S. Dalal, L. Delmolino & E.L. Androphy: Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J 12, 1847-52 (1993)

26. D.E. Wazer, X.L. Liu, Q. Chu, Q. Gao, V. Band: Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci USA 92, 3687-91 (1995)

27. A. Yilmaz, A.C. Gaide, B. Sordat, Z. Borbenyi, H. Lahm, A. Imam, M. Schreyer & Odartchenko: Malignant progression of SV40-immortalized human milk epithelial cells. Br J Cancer 68, 868-73 (1993)

28. P. Berthon, G. Goubin, B. Dutrillaux, A. Degeorges, A. Faille, C. Gespach & F. Calvo: Single step transformation of human breast epithelial cells by SV40 large T oncogene. Int J Cancer 52, 97-7 (1992)

29. J. Russo & I.H. Russo: The etiopathogenesis of breast cancer prevention. Cancer Letters 90, 81-89 (1995)

30. Y.F Hu, I.H. Russo, X. Ao & J. Russo: Mammary-derived growth inhibitor (MDGI) cloned from human breast epithelial cells is expressed in fully differentiated lobular structures. Int J Oncol 11, 5-11 (1997)

31. C.M. Phelan, C. Larsson, S. Baied, P.A. Futreal, M.H. Ruttledge, K. Morgan, P. Tonin, H. Hung, R.G. Korneluk, M.N. Pollak & S.A. Narod: The human mammary-derived growth inhibitor (MDGI) gene: Genomic structure and mutation analysis in human breast tumors. Genomics 34, 63-8 (1996)

32. M. Genardi, H. Tsihira, D.E. Anderson & G.F. Saunders: Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am J Hum Genet 45, 73-82 (1989)

33. H.T. Huynh, C. Larsson, S. Narod & M. Pollak: Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res 55, 2225-31 (1996)

34. K.A. Traul, K. Takayama, V. Kachevsky, R. J. Hink & J.S. Wolff: A rapid in vitro assay for carcinogenicity of chemical substances in mammalian cells utilizing an attachment independence endpoint. 2. Assay validations. J Appl Toxicol 1, 190-5 (1981)

35. D.L. Putnam, D.K. Park, J.S. Rhim, A.F. Stever & R.C. Ting: Correlation of cellular aggregation of transformed cells and their growth in soft agar and tumorigenic potential. Proc Soc Exp Biol Med 155, 487-94 (1977)

36. H.S. Feigelson, R.R. Ross, M.C. Yu, G.A. Coetzee, K.V. Reichardt & B.E. Henderson: Genetic susceptibility to cancer from exogenous and endogenous exposures. J Cell Biochem 25S, 15-22 (1996)

37. M.N. Gould, R.A. Lubet, G.J. Kellof & J.D. Haag: Inherited susceptibility and acquired allelic imbalance in rat mammary carcinogenesis. J Cell Biochem 25S, 37-40 (1996)

38. G. Calaf & J. Russo: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14, 483-92 (1993)

39. C.B. Harley: Telomere loss: mitotic clock or genetic time bomb? Mutation Res 256, 271-82 (1991)

40. E.H. Blackburn: Telomerase. Annu Rew Biochem 61, 113-29 (1992)

41. J.W. Shay, W.E. Wright & H. Werbin: Toward a molecular understanding of human breast cancer: A hypothesis. Breast Cancer Res Treat 25, 83-94 (1993)

42. S. Bacchetti & C.M. Counter: Telomeres and telomerase in human cancer. Int J Oncol 7, 423-32 (1995)

43. A.A. Avilion, M.A. Piatyszek, J. Gupta, J.W. Shay, S. Bacchetti & C.W. Greder: Human telomerase RNA and telomerase activity in immortal cells lines and tumor tissues. Cancer Res 56, 645-50 (1996)

44. Y.F. Hu, I.H. Russo, C.M. Slater & J. Russo: Regulation of telomerase activity by extracellular calcium in human breast epithelial cells (manuscript in preparation).

45. O.M. Pereira-Smith & J.R. Smith: Evidence for the recessive nature of cellular immortality. Science 221, 964-6 (1983)

46. Y. Xiong, G.J. Hannon, D. Zhang, D. Casso, R. Kobayashi & D. Beach: p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-4 (1993)

47. N. Barnabas, R. Moraes, G. Calaf, S. Estrada & J. Russo: Role of p53 in MCF-10F cell immortalization and chemically-induced neoplastic transformation. Int J Oncol 7, 1289-96 (1995)

48. Q. Gao Q, S.H. Hauser, X.L. Liu, D.E. Wazer, H. Madoc-Jones & V. Band: Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res 56, 3129-33 (1996)

49. L.S. Gollahon & J.W. Shay: Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12, 715-25 (1996)

50. J.Y. Chen, W.D. Funk, W.E. Wright, J.W. Shay & J.D. Minna: Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene 8, 2159-66 (1993)

51. Y.F. Hu & J. Russo: Expression of p21WAF-1 in MCF-10F cells. (unpublished data).

52. A. Kamb, N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day, B.E. Johnson & M.H. Skolnick: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-40 (1994)

53. A.J. Brenner & C.M. Aldaz: Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res 55, 2892-95 (1995)

54. O. Loughran, K.G. Edinogton, I.J. Berry, L.J. Clarke & E.K. Parkinson: Loss of heterozygosity of chromosome 9q21 is associated with the immortal phenotypes of neoplastic human head and neck keratinocytes. Cancer Res 54, 5045-49 (1994)

55. E.R. Jupe, X.T. Liu, J.L. Kiehlbauch, J.K. McClung & R.T. Dell’Orco: Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines. Exp Cell Res 218, 577-80 (1995)

56. E.R. Jupe, X.T. Liu, J.L. Kiehlbauch, J.K. McClung & R.T. Dell’Orco: The 3’ untranslated region of prohibitin and cellular immortalization. Exp Cell Res 224, 128-35 (1996)

57. J.J. White, D.H. Ledbetter, R.L. Eddy, Jr, T.B. Shows, D.A. Stewart, M.J. Nuell, V. Friedman, C.M. Wood, G.A. Owens, J.K. McClung, D.B. Danner & C.C. Morton: Genomics 11, 228-30 (1991)

58. T. Sato, H. Saito, J. Swensen, A. Olifant, C. Wood, D. Danner, T. Sakamoto, K. Takita, F. Kasumi, Y. Miki, M. Skolnick & Y. Nakamura: The human prohibitin gene, located on chromosome 17q21, is mutated in sporadic breast cancer. Cancer Res 52, 1643-46 (1992)

59. M.J. Nuell MJ, D.A. Stewart, L. Walker, V. Friedman, C.M. Wood, F.A. Owens, J.R. Smith, E.L. Schneider, R.T. Dell’Orco, C.K. Lumpkin, D.B. Danner & J.K. McClung: Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol 11, 1372-81 (1991)

60. N.A. Higgy, A.M. Salicioni, I.H. Russo, P.L. Zhang & J. Russo: Differential expression of human ferritin H chain gene in immortal human breast epithelial cells MCF-10F. Mol Carcinog 20, 332-339, 1997.

61. E. Abruzzese, P.N. Rao, M.J. Pettenati, M.J. Kute, S.V. Torti & F.M. Torti: The ferritin H gene is amplified in human breast cancer carrying an 11Q13 amplification. Proc Am Assoc Cancer Res 38, 415 (1997)

62. D.C. Yang, J.F. Head, F. Wang & R.L. Elliott: Transferrin receptor mRNA and ferritin H-chain mRNA expression are associated with prognostic indicators of breast cancer. Proc Am Assoc Cancer Res 38, 419 (1997)

63. I.D.C.G. Silva, Y.F. Hu, X. Ao, I.H. Russo, A.M. Salicioni, X. Yang & J. Russo: S100P Ca+2-binding protein overexpression is associated with immortalization and neoplastic transformation of human breast epithelial cells in vitro and tumor progression in vivo. Oncogene (submitted).

64. B.S. Cha, W.G. Thilly & H. Zarbl: N-Nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci USA 91, 3749-53 (1994)

65. D. Hockenbery, G. Nunez, C. Milliman & S.J. Korsmeyer: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 349, 334-6 (1990)

66. W.K. Chan, R. Poulsom, Q.L. Lu, K. Patel, W. Gregory, C.J. Fisher & A.M. Hanby: Bcl-2 expression in invasive mammary carcinoma: correlation with apoptosis, hormone receptors and p53 expression. J Pathol 169, 153A (1993)

67. J.M. Gee, J.F. Robertson, I.O. Ellis, P. Willsher, R.A. McClelland, H.B. Hoyle, S.R. Kyme, P. Finlay, R.W. Blamey & R.I. Nicholson: Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy Int J Cancer 59, 619-28 (1994)

68. M.F. Buckley, K.J.E. Sweeney, J.A. Hamilton, R.L. Sini, D.L. Manning, R.I. Nicholson, A. DeFazio, C.K.W. Watts, E.A. Musgrove & R.L. Sutherland: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-33 (1993)

69. J. Bartkova, J. Lukas, H. Muller, D. Lutzhoft, M. Strauss & J. Bartek: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57, 353-61 (1994)

70. C. Gillet, V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes & G. Peters: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54, 1812-7 (1994)

71. S.Y. Zhang, J. Camano, F. Cooper, X. Guo & A. Klein-Szanto: Immuno-histochemistry of cyclin D1 in human breast cancer. Am J Clin Path 102: 695-8 (1994)

72. D. Weistat-Saslow, M.J. Merino, E.M. Richard, J.A. Lawrence, R.F. Bluth, K.D. Wittenbel, J.F. Simpson, D.L. Page & P.A. Steeg: Overexpression of cyclin D mRNA distinguish invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1, 1257-60 (1995)

73. Y. Ning, J.L. Webber, A.M. Killary, D.H. Ledbetter, J.R. Smith & O.M. Pereira-Smith: Genetic analysis of indefinite division of human cells: Evidence for a cell senescence-related gene(s) on chromosome 4. Proc Natl Acad Sci USA 88, 5635-9 (1991)

74. O. Suguwara, M. Oshimura, M. Koi, L.A. Annab & J.C. Barrett: Induction of cellular senescence in immortalized cells by human chromosome 1. Science 247, 707-10 (1990)

75. S.R. Wolman, A.N. Mohamed, G.H. Heppner & H.D. Soule: Chromosomal markers of immortalization in human breast epithelium. Genes Chrom Cancer 10, 59-65 (1994)

76. F.A. Ray & P.M. Kraemer: Frequent deletions in nine newly immortal human cell lines. Cancer Genet Cytogenet 59, 39-44 (1992)

77. S.S. Banga, S.H. Kim, K. Hubbard, T. Dasgupta, K.K. Jha, P. Patsalis, R. Hauptschein, B. Gamberi, R. Dalla-Favera, P. Krarmer & H.L. Ozer: SEN6, a locus for SV-40-mediated immortalization of human cells, maps to 6q26-27. Oncogene 14, 313-21 (1997)

78. E. Savelieva, C.D. Belair, M.A. Newton, S. DeVries, J.W. Gray, F. Waldman & C.A. Reznikoff: 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papilloma virus 16 E7 transformed human uroepithelial cells. Oncogene 14, 551-60 (1997)

79. E.Y.-H.P. Lee: Tumor suppressor genes and their alterations in breast cancer. Sem Cancer Biol 6, 119-25 (1995)

80. L.A. Donehower: Effects of p53 mutation on tumor progression: recent insights from mouse tumor models. Biochim Biophy Acta 1242, 171-6 (1996)

81. W.B. Coleman & G.J. Tsongalis: Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41, 644-57 (1995)

82. I. Bieche & R. Lidereau: Genetic alterations in breast cancer. Gene Chrom Cancer 14, 227-51 (1995)

83. J.R. Eshleman & S.A. Markowitz: Microsatellite instability in inherited and sporadic neoplasms. Curr Opinion Oncol 7, 83-9 (1995)

84. L.A. Loeb: Many mutations in cancer. Cancer Surveys 28, 329-42 (1996).

85. G.H. Heppner & F.R. Miller: The cellular basis of tumor progression. Int Rev Cytol 77, 1-56 (1997)

86. J.L. Weber & P.E. May: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44, 388-96 (1989)

87. M. Litt & J.A. Luty: A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am J Hum Genet 44, 397-401 (1989)

88. L.A. Aaltonen, P. Peltomaki, F.S. Leach, P. Sistonen, L. Pylkkanen, J.P. Mecklin, H. Jarvinen, S.M. Powell, J. Jen, S.R. Hamilton, G. Petersen, K.V. Kinzler, B. Vogelstein & A. Dela Chaplelle: Clues to the pathogenesis of familial colorectal cancer. Science 260, 812-16 (1993)

89. S.N. Thibodeau, G. Bren & D. Schaid: Microsatellite instability in cancer of the proximal colon. Science 260, 816-9 (1993)

90. Y. Ionov, M.A. Peinado, S. Malkhosyan, D. Shibata & M. Perucho: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558-61 (1993)

91. A.K. El-Naggar, K. Hurr, V. Huff, G.L. Clayman, M.A. Luna & J.G. Batsakis: Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am J Pathol 148, 2067-72 (1996)

92. J. Adachi, M. Shiseki, T. Okazaki, G. Ishimaru, M. Noguchi, S. Hirohashi & J. Yokota: Microsatellite instability in primary and metastatic lung carcinomas. Gene Chrom Cancer 14, 301-6 (1995)

93. M. Visser, J. Bras, C. Sijmons, P. Devilee, L.C. Wijnaendts, J.C. van der Linden, P.A. Voute & F. Baas: Microsatellite instability in childhood rhabdomyosarcoma is locus specific and correlates with fractional allelic loss. Proc Natl Acad Sci USA 93, 9172-6 (1996)

94. R.B. Gartenhaus: Microsatellite instability in hematologic malignancies. Leukemia & Lymphoma 25, 455-61 (1997)

95. K. Peris, G. Keller, S. Chimenti, A. Amantea, H. Kerl & H. Hofler: Microsatellite instability and loss of heterozygosity in melanoma. J Invest Dermatol 105, 625-628 (1995)

96. A. LatiL, O. Cussenot, G. Fournier & R. Lidereau: The BRCA2 gene is not relevant to sporadic prostate tumours. Int J Cancer 66, 282-3 (1996)

97. A.K. El-Naggar, K. Hurr, J. Kagan, A. Gillenwater, D. Callender, M.A. Luna & H.J.G. Batsakis: Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surgical Pathol 21, 691-7 (1997)

98. M. Li, Z.F. Zhang, V.E. Reuter, C. Cordon-Cardo: Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol 149, 229-35 (1996)

99. G. Togo, N. Toda, F. Kanai, N. Kato, Y. Shiratori, K. Kishi, F. Imazeki, M. Makuuchi & M. Omata: A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56, 5620-23 (1996)

100. P.E. Berg, J. Liu, J. YinJ, M.G. Rhyu, C.N. Frantz & S.J. Meltzer: Microsatellite instability is infrequent in neuroblastoma. Cancer Epidemiol Biomark Prevent 4, 907-9 (1995)

101. E. Dams, E.J. van de Kelft, J.J. Martin, J. Verlooy & P.J. Willems: Instability of microsatellites in human gliomas. Cancer Res 55, 1547-9 (1995)

102. A.A. Larson, S. Kern, R.L. Sommers, J. Yokota, W.K. Cavenee & G.M. Hampton: Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res 56, 1426-31 (1996)

103. A. Berchuck: Biomarkers in the endometrium. J Cell Biochem-Suppl 23, 174-8 (1995)

104. R. Wooster, A.M. Cleton-Jansen, N. Collins, J. Mangion, R.S. Cornelis, C.S. Cooper, B.A. Gusterson, B.A.J. Ponder, A. von Deimling, O.D. Wiestler, C.J. Cornelisse, P. Devilee & M.R. Straton: Instability of short tandem repeats (microsatellites) in human cancers. Nature Genet 6, 152-6 (1994)

105. C.J. Yee, N. Roodi, C.S. Verrier & F.F. Parl: Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54, 1641-4 (1994)

106. J.A. Shaw, T. Walsh, S.A. Chappell, N. Carey, K. Johnson & R.A. Walker: Microsatellite instability in early sporadic breast cancer. Br J Cancer 73, 1393-7 (1996)

107. T. Toyama, H. Iwase, H. Yamashita, H. Iwata, T. Yamashita, K. Ito, Y. Hara, M. Suchi, T. Kato, T. Nakamura & S. Kobayashi: Microsatellite instability in sporadic human breast cancers. Int J Cancer 68, 447-51 (1996)

108. T. Toyama, H. Iwase, H. Iwata, Y. Hara, Y. Omoto, M. Suchi, T. Kato, T. Nakamura & S. Kobayashi: Microsatellite instability in in situ and invasive sporadic breast cancers of Japanese women. Cancer Lett 108, 205-9 (1996)

109. J. I. Risinger, J.C. Barrett, P. Watson, H.T. Lynch & J. Boyd: Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 7, 1836-43 (1996)

110. R.A. Walker, J.L. Jones, S. Chappell, T. Walsh & J.A. Shaw: Molecular pathology of breast cancer and its application to clinical management. Cancer Metastasis Rev 16, 5-27 (1997)

111. E.B. Rush, J.E. Calvano, K.J. van Zee, A.D. Zelenetz & P.I. Borgen: Microsatellite instability in breast cancer. Ann Surg Oncol 4, 310-5 (1997)

112. G. Souvinos, H. Kiaris, A. Tsikkinis, S. Vassilaros & D.A. Spandidos: Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumor Biol 18, 157-66 (1997)

113. P. Karnik, S. Plummer,G. Casey, J. Myles, R. Tubbs, J. Crowe & B.R.G. Williams: Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis. Hum Mol Genet 4, 1889-94 (1995)

114. C.M. Aldaz, T. Chen, A. Sahin, J. Cunningham & M. Bondy: Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55, 3976-81 (1995)

115. E.K. Dillon, W.B. de Boer,J.M. Papadimitriou & G.R. Turbett: Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Caner 76, 156-162(1997)

116. M. Kasami, C.L. Vnencak-Jones, S. Manning, W.D. Dupont & D.L. Page: Loss of heterozygosity and microsatellite instability in breast hyperplasia. Am J Pathol 150, 1925-32 (1997)

117. J.R. Eshleman & S.D. Markowitz: Mismatch repair defects in human carcinogenesis. Hum Mol Genet 5, 1489-94 (1996)

118. C.R. Boland: Roles of the DNA mismatch repair genes in colorectal tumorigenesis. Int J Cancer 69, 47-9 (1996)

1 19. Y. Huang, B. Bove, Y. Wu, I.H. Russo, Q. Tahin, X. Yang, A. Zekri & J. Russo: Carcinogenesis (submitted)

120. J.C. Murray, K.H. Buetow, J.L. Waber, S. Ludwigsen, T. Scherpbier-Heddema, F. Manion, J. Quillen, V.C. Sheffield, S. Sunden, G.M. Duyk, J. Weissenbach, G. Gyapay, C. Dib, J. Morrissette, G.M. Lathrop, A. Vignal, R. White, N. Matsunami, S. Gerken, R. Melis, H. Albertsen, R. Plaetke, S. Odelberg, D. Ward, J. Dausset, D. Cohen& H.Cann: A comprehensive human linkage map with centimorgan density. Science 265, 2049-2054 (1994)

121. Y. Wu, N. Barnabas, I.H. Russo, X. Yang & J. Russo: Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. Carcinogenesis 18, 1069-74 (1997)

122. L.A. Loeb: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51, 3075-9 (1991)

123. L.A. Loeb: Cancer cells exhibit a mutator phenotype. In: Advances in Cancer Research. Academic Press (1998) pp25-56.

124. E. Eisenstadt, A.J. Warren, J. Porter, D. Atkins & J.H. Miller: Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci USA 79,1945-9 (1982)

125. M.S. Greenblatt, W.P. Bennett, M. Hollstein & C.C. Harris: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-78 (1994)

126. A. Prisieux, S. Lim, J. Groopman & M. Ozturk: Selective targeting of p53 gene mutation hotspots in human cells by etiologically defined carcinogens. Cancer Res 51, 6185-9 (1991)

127. D. Malkin: p53 and the Li-Fraumeni syndrome. Biochim Biophy Acta 1198, 197-213 (1994)

128. I. Mellon, D.K. Rajpal, M. Koi,C.R. Boland & G.N. Champe: Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272, 557-60 (1996)

129. E.A. Sia, S. Jinks-Robertson, T.D. Petes: Genetic control of microsatellite stability. Mutat Res 383, 61-70 (1997)

130. R.E.K. Fournier & F.H. Ruddle: Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci USA 74, 319-23 (1977)

131. E.J. Stanbridge: Genetic analysis of human malignancy using somatic cell hybrids and manochromosome transfer. Cancer Surv 7, 317-24 (1988)

132. M. Noda: Mechanisms of reversion. FASEB J 7, 834-846 (1993)

133. M. Oshimura: Lessons learned from studies on tumor suppression by microcell-mediated chromosome transfer. Environ Health Persp 93, 57-58 (1991)

134. M.J. Anderson & E.J. Stanbridge: Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 7, 826-33 (1993)

135. J.D. Hunt: Evaluation of phenotypic alteration by microcell-mediated chromosome transfer. Analytical Biochem 238, 107-16 (1996)

136. B.E. Weissman, P.J. Saxon, S.R. Pasquale, G.R. Jones, A.G. Geiser & E.J. Stanbridge: Introduction of a normal human chromosome 11 into a Wilm’s tumor cell line controls its tumorigenic expression. Science 236, 175-80 (1987)

137. M. Oshimura, H. Kugoh, M. Koi, M. Shimuzu, H. Yamada, H. Satoh & J.C. Barrett: Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42, 135-42 (1990)

138. H. Yamada, N. Wake, S. Fujimoto, J.C. Barrett & M. Oshimura: Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-medicated chromosome transfer. Oncogene 5, 1141-7 (1990)

139. K. Tanaka, M. Oshimura, R. Kikuchi, M. Seki, T. Hayashi & M. Miyaki: Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349, 340-2 (1991)

140. X.W. Wang, X. Lin, C.B. Klein, R.K. Bhamra, Y.W. Lee & M. Costa: A conserved region in human and Chinese hamster X chromosome can induce cellular senescence of nickel-transformed Chinese hamster cell line. Carcinogenesis 13, 555-61 (1992)

141. T. Ichikawa, Y. Ichikawa, J. Dong, A.L. Howkins, C.A. Griffin, W.B. Isaacs, M. Oshimura, J.C. Barrett & J.T. Isaacs: Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52, 3486-90 (1992)

142. M. Goyette, K. Cho, C.L. Fasching, D.B. Levy, K.W. Kinzler, C. Paraskeva, B. Vogelstein & E.J. Stanbridge: Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Bio 12, 1387-95 (1992)

143. G. Casey, S. Plummer, G. Hoeltge, D. Scanlon, C. Fasching, E.J. Stanbridge: Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Hum Mol Genet 2, 1921-7 (1993)

144. H. Satoh, P.W. Lamb, J.T. Dong, H. Everitt, C. Boreiko, M. Oshimura &J.C. Barrett: Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol Carcinog 7, 157-64 (1993)

145. D.R. Welsh, P. Chen, M.E. Miele, C.T. McGary, J.M. Bower, E.J. Stanbridge & B.E. Weissman: Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9, 255-62 (1994)

146. M. Negrini, S. Sabbioni, S. Haldar, L. Possati, A. Castagnoli, A. Corallini, G. Barbanti-Brodano & C.M. Croce: Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res 54, 1818-24 (1994)

147. M. Negrini, S. Sabbioni, L. Possati, S. Rattan, A. Corallini, G. Barbanti-Brodano & C.M. Croce: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 54: 1331-6 (1994)

148. M.A. Yoshida, M. Shimizu, T. Ikeuchi, A. Tonomura, J. Yokota & M. Oshimura: In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion. Mol Carcinog 9, 114-21 (1994).

149. A. Yoshida, T. Asaga, C. Masuzawa & S. Kawahara: Alteration of tumorigenicity in undifferentiated thyroid carcinoma cells by introduction of normal chromosome 11. J Surg Oncol 55, 170-4 (1994)

150. M.J. Anderson, G. Casey, C.L. Gasching & E.J. Stanbridge: Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080. Gene Chrom Cancer 9, 266-81 (1994)

151. Y.S. Murakami, A.R. Brothman, R.J. Leach & R.L. White: Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 55, 3389-94 (1995)

152. M. Theile, Z. Seitz, W. Arnold, B. Jandrig, R. Frege, P.M. Schlag, W. Haensch, H. Guski, K.J. Winzer, J.C. Barrett & S. Scherneck: A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13, 677-85 (1996)

153. N. Uzawa, M.A. Yoshida, M. Oshimura & T. Ikeuchi: Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell-mediated chromosome transfer. Oncogene 11, 1997-2004 (1995)

154. S.J. Plummer, L. Adams, J.A. Simmons & G. Casey: Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25. Oncogene 14, 2339-45 (1997)

155. M. Oshimura, M. Shimizu & H. Kugoh: Genetic regulation of telomerase in a multiple pathways model to cellulose senescence. Hum Cell 9, 301-8 (1996)

156. K.G. Klein & N.P. Bouck: The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for a human fibrosarcoma line. Cancer Genet Cytogenet 73, 109-21 (1994)

157. I. Horikawa, H. Yamada, H. Kugoh, Y. Yuasa, M. Suzuki & M. Oshimura: Subchromosomal mapping of a putative transformation suppressor gene on human chromosome 1. Jpn J Cancer Res 86, 444-50 (1995)

158. M. Shimizu, J. Yokota, N. Mori, T. Shuin, M. Shinoda, T. Masaaki & M. Oshimura: Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene 5, 185-94 (1990)

159. P. Remessi, F. Gualandi, C. Morlli, C. Trabanelli, Q. Wu, L. Possati, M. Montesi, J.C. Barrett & G. Barbanti-Brodano: Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer. Oncogene 9, 3467-74 (1994)

160. M. Koi, H. Morita, H. Yamada, H. Satoh, J.C. Barrett & M. Oshimura: Normal human chromosome 11 suppressed tumorigenicity human cervical tumor cell line SiHa. Mol Carcinog 2, 12-21 (1989)

161. G. Robertson, A. Coleman & T.G. Lugo: A malignant melanoma tumor suppressor on human chromosome 11. Cancer Res 56, 4487-92 (1996)

162. A.L. Menke, R.C. van Ham, E. Sonneveld, A. Shvarts, E.J. Stanbridge, K. Miyagawa, A.J. van der EB & A.G. Jochemsen: Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilm’s tumor 1 gene. Int J Cancer 63, 76-85 (1995)

163. M. Theile, S. Hartmann, H. Naundorf, D.R. Birgitelbe, H. Krause, W. Deppert, J.C. Barrett & S. Scherneck: Wild-type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells after transfer of normal chromosome 17. Int J Oncol 4, 1067-75 (1994)

164. A. Umar, M. Koi, J.I. Risinger, W.E. Glaab, K.R. Tindal, R.D. Kolodner, C.R. Boland, J.C. Barrett & T.A. Kundel: Correction of hypermutability, N-methyl-N’-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 57, 3949-55 (1997)

165. D.J. Chen, B.L. Marrone, T. Nguyen, M. Stackhouse, Y. Zhao, M.J. Siciliano: Regional assignment of a human DNA repair gene (XRCC5) to 2q34 by X-ray hybrid mapping. Genomics 21, 423-7 (1992)

166. M. Koi, A. Umar, D.P. Chauhan, S.P. Cherian, J.M. Carethers, T.A. Kunkel & C.R. Boland: Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N’-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 54, 4308-12 (1994)

167. A. Kurimasa, Y. Nagata, M. Shimizu, E. Mitsuru, Y. Nakamura & M. Oshimura: A human gene that restores the DNA-repair defect in SCID mice is located on 8p11.1-q11.1. Hum Genet 93, 21-6 (1994)

168. S. Kodama, K. Komatsu, Y. Okumura & M. Oshimura: Suppression of X-ray-induced chromosome aberration in ataxia telangiectasia cells by introduction of a normal human chromosome 11. Mutation Res 293, 31-7 (1992)

169. Y. Ejima, M. Oshimura, M.S. Sassaki: Determination of the chromosomal site for the human radiosensitive ataxia telangiectasia gene by chromosome transfer. Mutation Res 250, 337-43 (1991)

170. T. Ichikawa, N. Nihei, H. Kuramochi, Y. Kawana, A.M. Killary, C.W. Rinker-Scharffer, J.C. Barrett, J.T. Isaacs, H. Kugoh, M. Oshimura & J. Shimazaki: Metastasis suppressor genes for prostate cancer. Prostate-Suppl 6, 31-5 (1996)

171. N. Nihei, T. Ichikawa, Y. Kawana, H. Kuramochi, H. Kugoh, M. Oshimura, I. HayataI, J. Shimazaki & H. Ito: Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell-mediated chromosome transfer. Gene Chrom Cancer 17, 260-8 (1995)

172. K.K. Phillips, D.R. Welsh, M.E. Miele, J.H. Lee & B.E. Weissman: Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 56, 1222-7 (1996)

173. C.W. Rinker-Schaeffer, A.L. Hawkins, N. Ru, J. Dong, G. Stoica, C.A. Griffin, T. Ichikawa, J.C. Barrett & J.T. Isaacs: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 54, 6249-56 (1994)

174. X. Yang, Y. Huang, I.H. Russo, J.C. Barrett and J. Russo: Chromosomes 11 and 17 revert transformed phenotypes induced by benzo(a)pyrene (BP) in human breast epithelial cells (HBEC). Proc Am. Assoc. Cancer Res 39: 185 (1998)

175. J. Taylor-Papadimitriou, F. Berdichevsky, B. D’Souza & J. Burchell: Human models of breast cancer. Cancer Surveys 16, 59-78 (1993)

176. T. Kuroki & N.-H. Huh: Why are human cells resistant to malignant cell transformation in vitro. Jpn J Cancer Res 84, 1091-100 (1993)